Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001062993-22-000247

Options or other derivatives

  • Director acquired 7,943 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Persson Magnus Director 2021-12-31 Grant or award · Stock Option (Right to Buy) +7,943 7,943 D: show line 1 in the form
Loading xslF345X03/form4.xml…